{"id":111734,"date":"2023-10-12T16:53:55","date_gmt":"2023-10-12T11:23:55","guid":{"rendered":"https:\/\/tradebrains.in\/features\/?p=111734"},"modified":"2023-10-12T16:54:01","modified_gmt":"2023-10-12T11:24:01","slug":"small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray","status":"publish","type":"post","link":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/","title":{"rendered":"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray"},"content":{"rendered":"<div class=\"trade-content_2\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-883144804\"><p><a href=\"https:\/\/tradebrains.in\/get\/telegram\/\"><img decoding=\"async\" class=\"alignnone wp-image-101992\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2023\/01\/telegram-channel-300x119.png\" alt=\"\" width=\"148\" height=\"59\" \/><\/a> <a href=\"https:\/\/news.google.com\/publications\/CAAqBwgKMN3Epgswxc--Aw?hl=en-IN&amp;gl=IN&amp;ceid=IN%3Aen\"><img decoding=\"async\" class=\"alignnone wp-image-123430\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png\" alt=\"follow-on-google-news\" width=\"222\" height=\"61\" srcset=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-300x82.png 300w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news-150x41.png 150w, https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2024\/05\/follow-on-google-news.png 468w\" sizes=\"(max-width: 222px) 100vw, 222px\" \/><\/a><\/p>\n<\/div><p>Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.&nbsp;<\/p><div class=\"trade-content_7\" style=\"margin-left: auto;margin-right: auto;text-align: center;\" id=\"trade-3440795261\"><!-- Composite Start --> \r\n <div id=\"M923760ScriptRootC1549812\"> \r\n <\/div> \r\n <script src=\"https:\/\/jsc.mgid.com\/t\/r\/tradebrains.in.1549812.js\" async> \r\n <\/script> \r\n <!-- Composite End --><\/div><p>Shares of <strong><a href=\"https:\/\/portal.tradebrains.in\/stock\/SHILPAMED\/consolidated\" target=\"_blank\" rel=\"noreferrer noopener\">Shilpa Medicare Ltd<\/a><\/strong> closed at Rs. 347.05 per share, up by 2.84 percent from previous closing price of Rs. 337.35 per share.\u00a0<\/p><p>Such bullish stock price movements were observed after the company through a regulatory filing on Bombay stock exchange (BSE) announced that they received approval from the Office of the Directorate of Ayurveda and Unani Services for manufacture and sales of Oral Mucositis Spray.&nbsp;<\/p><p>Spray treatment option is available for the first time in India for Oral Mucositis and it will be sold under brand name \u201cORAAL\u201d. The composition of ORAAL is protected by a granted patent in India until November 2033 and it also has been accepted and approved by the Indian Dental Association (IDA).&nbsp;<\/p><div class=\"trade-content_5\" id=\"trade-2221910993\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_2_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"7925020301\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><p>The company claims that ORAAL can be used for the treatment of all grades of Mucositis. ORAAL is backed by required scientific proof for the treatment of Oral Mucositis.&nbsp;<\/p><p>Looking at the financial statements, company\u2019s revenue has decreased marginally by 0.38 percent to Rs. 260.18 crores in Q1FY24 from Rs. 261.16 crores in Q1FY23, in the same time period net profit increased by 38.82 percent to Rs. 1.18 crores from Rs. 0.85 crores.&nbsp;<\/p><p>Talking about the financial ratios, the company reported return on equity (ROE) of -1.71 percent and return on capital employed (ROCE) of 0.8 percent in the last financial year.&nbsp;<\/p><p>Shilpa Medicare is involved in the business of manufacturing high quality Active Pharmaceuticals Ingredients (APIs), Intermediates, Formulations, New Drug delivery system, Peptides, Biotech products, and Specialty chemicals using sophisticated technology. The company is one of the world&#8217;s leading suppliers of Oncology\/ Non Oncology APIs and intermediates.&nbsp;<\/p><p><strong>Written by: Vinit Israni&nbsp;<\/strong><\/p><h4 class=\"wp-block-heading\" id=\"h-disclaimer\"><strong>Disclaimer<\/strong><\/h4><div class=\"wp-block-image\"><figure class=\"aligncenter size-medium\"><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/02\/warning-disclaimer-300x300.png\" alt=\"\" class=\"wp-image-26306\"\/><\/figure><\/div><p><strong>The views and investment tips expressed by investment experts\/broking houses\/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.<\/strong><\/p><div class=\"trade-content-10\" id=\"trade-2244838697\"><script async src=\"https:\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-4023722985638610\"\r\n     crossorigin=\"anonymous\"><\/script>\r\n<!-- in_content_3_news -->\r\n<ins class=\"adsbygoogle\"\r\n     style=\"display:block\"\r\n     data-ad-client=\"ca-pub-4023722985638610\"\r\n     data-ad-slot=\"2969612066\"\r\n     data-ad-format=\"auto\"\r\n     data-full-width-responsive=\"true\"><\/ins>\r\n<script>\r\n     (adsbygoogle = window.adsbygoogle || []).push({});\r\n<\/script><\/div><div class=\"trade-after-content\" id=\"trade-855754153\"><div id=\"taboola-below-article-thumbnails\"><\/div>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({\r\n    mode: 'alternating-thumbnails-a',\r\n    container: 'taboola-below-article-thumbnails',\r\n    placement: 'Below Article Thumbnails',\r\n    target_type: 'mix'\r\n  });\r\n<\/script>\r\n<script type=\"text\/javascript\">\r\n  window._taboola = window._taboola || [];\r\n  _taboola.push({flush: true});\r\n<\/script><\/div>","protected":false},"excerpt":{"rendered":"<p>Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.&nbsp; Shares of Shilpa Medicare Ltd closed at Rs. 347.05 per share, up by 2.84 percent from previous closing price of Rs. 337.35 per share.\u00a0 Such bullish stock price movements were observed after [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":39466,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[31,1789],"tags":[13156,13157,13155,948,936],"class_list":["post-111734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-trending-news","tag-shilpa-medicare-latest-news","tag-shilpa-medicare-new-product","tag-shilpa-medicare-share-price","tag-stock-market","tag-stock-market-news"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v20.5 (Yoast SEO v25.0) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray - Trade Brains Features<\/title>\n<meta name=\"description\" content=\"Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.\u00a0\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray\" \/>\n<meta property=\"og:description\" content=\"Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.\u00a0\" \/>\n<meta property=\"og:url\" content=\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/\" \/>\n<meta property=\"og:site_name\" content=\"Trade Brains Features\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/TradeBrainsOfficial\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-10-12T11:23:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-10-12T11:24:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"854\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Trade Brains\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:site\" content=\"@TradeBrainsGrp\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Trade Brains\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/\",\"url\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/\",\"name\":\"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray - Trade Brains Features\",\"isPartOf\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg\",\"datePublished\":\"2023-10-12T11:23:55+00:00\",\"dateModified\":\"2023-10-12T11:24:01+00:00\",\"author\":{\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\"},\"description\":\"Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.\u00a0\",\"breadcrumb\":{\"@id\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#primaryimage\",\"url\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg\",\"contentUrl\":\"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg\",\"width\":1280,\"height\":854,\"caption\":\"BSE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/tradebrains.in\/features\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/tradebrains.in\/features\/#website\",\"url\":\"https:\/\/tradebrains.in\/features\/\",\"name\":\"Trade Brains\",\"description\":\"Stock Market NSE\/BSE Latest News\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/tradebrains.in\/features\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666\",\"name\":\"Trade Brains\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g\",\"caption\":\"Trade Brains\"},\"sameAs\":[\"http:\/\/tradebrains.in\/\"],\"url\":\"https:\/\/tradebrains.in\/features\/author\/trade-brains\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray - Trade Brains Features","description":"Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.\u00a0","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/","og_locale":"en_US","og_type":"article","og_title":"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray","og_description":"Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.\u00a0","og_url":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/","og_site_name":"Trade Brains Features","article_publisher":"https:\/\/www.facebook.com\/TradeBrainsOfficial\/","article_published_time":"2023-10-12T11:23:55+00:00","article_modified_time":"2023-10-12T11:24:01+00:00","og_image":[{"width":1280,"height":854,"url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg","type":"image\/jpeg"}],"author":"Trade Brains","twitter_card":"summary_large_image","twitter_creator":"@TradeBrainsGrp","twitter_site":"@TradeBrainsGrp","twitter_misc":{"Written by":"Trade Brains","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/","url":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/","name":"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray - Trade Brains Features","isPartOf":{"@id":"https:\/\/tradebrains.in\/features\/#website"},"primaryImageOfPage":{"@id":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#primaryimage"},"image":{"@id":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#primaryimage"},"thumbnailUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg","datePublished":"2023-10-12T11:23:55+00:00","dateModified":"2023-10-12T11:24:01+00:00","author":{"@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666"},"description":"Shares of this small cap pharmaceutical company gained 2.84 percent after the company received approval for manufacture and sale of Oral Mucositis Spray.\u00a0","breadcrumb":{"@id":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#primaryimage","url":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg","contentUrl":"https:\/\/tradebrains.in\/features\/wp-content\/uploads\/2022\/05\/BSE-21-Cover-Image.jpg","width":1280,"height":854,"caption":"BSE"},{"@type":"BreadcrumbList","@id":"https:\/\/tradebrains.in\/features\/small-cap-stock-gained-3-after-it-receives-approval-for-their-new-oral-mucositis-spray\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/tradebrains.in\/features\/"},{"@type":"ListItem","position":2,"name":"Small cap stock gained 3% after it receives approval for their new Oral Mucositis Spray"}]},{"@type":"WebSite","@id":"https:\/\/tradebrains.in\/features\/#website","url":"https:\/\/tradebrains.in\/features\/","name":"Trade Brains","description":"Stock Market NSE\/BSE Latest News","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/tradebrains.in\/features\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/640937d840c7695c8f8995dd15ae0666","name":"Trade Brains","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/tradebrains.in\/features\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bd7d6331c5ab74181158fb2f0f0d9eada16909507ed513a20867478cf3bbdd43?s=96&d=mm&r=g","caption":"Trade Brains"},"sameAs":["http:\/\/tradebrains.in\/"],"url":"https:\/\/tradebrains.in\/features\/author\/trade-brains\/"}]}},"_links":{"self":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/111734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/comments?post=111734"}],"version-history":[{"count":1,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/111734\/revisions"}],"predecessor-version":[{"id":111735,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/posts\/111734\/revisions\/111735"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media\/39466"}],"wp:attachment":[{"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/media?parent=111734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/categories?post=111734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tradebrains.in\/features\/wp-json\/wp\/v2\/tags?post=111734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}